Crystallization Conference 2013 – Science for Business
MUMBAI, February 26, 2013
MUMBAI, February 26, 2013 /PRNewswire/ --
CPhI conferences announces a meeting of experts in the pharmaceuticals
industry speaking on an area of vital importance in developing high quality
APIs, taking place from 16 - 17 April 2013 at Hilton International Airport ,
Mumbai India .
(Logo: http://photos.prnewswire.com/prnh/20130226/599595-a ) (Logo:
http://photos.prnewswire.com/prnh/20130226/599595-b ) (Logo:
Dr. Allan S. Myerson, Professor of the Practice of Chemical Engineering,
Massachusetts Institute of Technology (USA)
" Crystallization is a crucial purification step in the pharmaceutical,
chemical and food industries.Control of purity, crystal size, crystal shape
and polymorphism is a major factor in crystallization process development and
downstream product development ."
Dr. Myerson presents on continuous crystallization of pharmaceuticals which is
one of his core area of expertise.
Dr. Robin Rogers, Robert Ramsay Chair of Chemistry, University of Alabama
(USA) and Editor-in-Chief Crystal Growth & Design
" Understanding and controlling crystallization of an API can make or break a
company, while finding new crystalline forms or crystallization processes can
lead to new and exciting business opportunities. "
Dr. Robin will be discussing issues around what happens when co-crystals don't
Dr. Preetam Ghogale , Head Pre-formulations, Piramal Enterprises
" Crystallization pays! You just need to understand it better ."
Dr. Preetam presents the role of solubility during crystallization by
evaluating different solvent systems and combinations to achieve right
Other experts include :
*Dr. Agam Sheth , Principal Scientist, Merck Research Laboratories (USA)
*Dr. Anant Paradkar, Director, Center for Pharmaceutical Engineering
Science, University of Bradford (UK)
*Mr. Sethu Madhavan , Director Manufacturing, Teva API India and many
The Crystalization conference has been designed keeping the science for
business perspective in mind. It addresses the most critical challenges of the
pharmaceutical industry. There are discussions around techniques to achieve
smooth scale up involving crystallization procedure. Furthermore, the
important area of particle size, which is a key for developing APIs through
crystallization,will be covered in depth. Crystallization is of vital
importance for generics working on Polymorphs and hence there is a highlighted
session on how crystallization can be effectively carried out to develop
This event has already generated interest in the industry with delegate
registrations made by companies like Cipla , Ranbaxy Laboratories , Lupin ,
USV , Unimark Remedies , Shasun Pharmaceuticals , Alkem Laboratories ,
Aurobindo Pharma , Watson Pharma , Aarti Industries , Vardhman Chemtech , DSM
Sinochem India , Srikrishna Pharma and so on.
Find out more about Crystallization 2013 conference on
CPhI India is the largest and most important meeting place for the Indian
pharma industry. Each year CPhI attracts around 850 exhibitors and 30,000
visitors to the show, providing us with an unrivalled reach to all the key
decision makers in the Indian Pharma industry.
About UBM India
UBM India is a subsidiary of UBM plc, which is the second largest independent
exhibition organiser in the world. It is the largest trade exhibition
organiser in India, responsible for 26 exhibitions in different locations
across the country. The company is also involved in the organisation of
conference programmes throughout India and in the publications of trade
journals and magazines. For further details please visit the UBM India
Primary Media Contact: Shwetha Prabhu, firstname.lastname@example.org ,
Press spacebar to pause and continue. Press esc to stop.